Al Hammadi’s net profit falls 21% to SAR 79.4 mln in 9M 2021

11/11/2021 Argaam Exclusive

View other reports

Al Hammadi Company for Development and Investment reported a net profit after Zakat and tax of SAR 79.4 million for the first nine months of 2021, a decline of 21% from SAR 100.6 million in a prior-year period.

The drop in earnings was driven by SAR 8.8 million loss from discontinued operations of Al Hammadi Olaya Hospital, decreased sales of subsidiaries and higher provisions.

Financials (M)

Item	9m 2020	9m 2021	Change‬
Revenues	533.59	670.10	25.6 %
Gross Income	184.35	255.52	38.6 %
Operating Income	84.57	105.97	25.3 %
Net Income	100.61	79.42	(21.1 %)
Average Shares	160.00	160.00	-
EPS (Riyals)	0.63	0.50	(21.1 %)

Q3 2021 net profit after Zakat and tax plunged 90% year-on-year (YoY) to SAR 3.6 million, driven by SAR 36.7 million in loss from the discontinued operations of Al Hammadi Olaya Hospital for the current quarter, and subdued sales of subsidiaries.

The company also cited higher provisions for credit loss and increased Zakat expenses.

Current Quarter Comparison (M)

Compared With The

Item	Q3 2020	Q3 2021	Change‬
Revenues	207.85	219.92	5.8 %
Gross Income	77.59	88.16	13.6 %
Operating Income	43.13	49.65	15.1 %
Net Income	36.57	3.58	(90.2 %)
Average Shares	160.00	160.00	-
EPS (Riyals)	0.23	0.02	(90.2 %)

Item	Q2 2021	Q3 2021	Change‬
Revenues	223.90	219.92	(1.8 %)
Gross Income	79.96	88.16	10.3 %
Operating Income	33.63	49.65	47.6 %
Net Income	40.31	3.58	(91.1 %)
Average Shares	160.00	160.00	-
EPS (Riyals)	0.25	0.02	(91.1 %)

On a quarterly basis, net earnings plummeted 91.1%.

Total shareholders’ equity (excluding minority interest) increased by 3.2% YoY to SAR 1.72 billion for the nine-month period.

View more financial results

Financial results (Million)

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
Q1 2012	-	-	-	-	-	-
Q2 2012	-	-	-	-	-	-
Q3 2012	-	-	-	-	-	-
Q4 2012	-	-	-	-	-	-
2012	378.68	14.5 %	163.11	10.5 %	92.34	0.2 %
Q1 2013	104.84	-	47.34	-	30.09	-
Q2 2013	108.85	-	45.84	-	22.74	-
Q3 2013	96.26	-	36.81	-	19.02	-
Q4 2013	124.13	-	55.17	-	34.34	-
2013	434.08	14.6 %	185.16	13.5 %	112.10	21.4 %
Q1 2014	122.04	16.4 %	54.71	15.6 %	35.96	19.5 %
Q2 2014	121.66	11.8 %	53.68	17.1 %	35.77	57.3 %
Q3 2014	108.83	13.1 %	44.74	21.5 %	24.77	30.3 %
Q4 2014	129.43	4.3 %	55.99	1.5 %	34.52	0.5 %
2014	481.96	11.0 %	209.11	12.9 %	130.95	16.8 %
Q1 2015	129.48	6.1 %	50.64	(7.4 %)	33.35	(7.3 %)
Q2 2015	137.36	12.9 %	63.56	18.4 %	37.91	6.0 %
Q3 2015	136.80	25.7 %	57.97	29.6 %	31.92	28.8 %
Q4 2015	157.70	21.8 %	68.06	21.6 %	40.39	17.0 %
2015	561.33	16.5 %	240.24	14.9 %	143.57	9.6 %
Q1 2016	144.16	11.3 %	54.75	8.1 %	26.66	(20.0 %)
Q2 2016	138.08	0.5 %	57.56	(9.5 %)	27.63	(27.1 %)
Q3 2016	141.35	3.3 %	56.48	(2.6 %)	25.97	(18.6 %)
Q4 2016	182.65	15.8 %	73.35	7.8 %	18.58	(54.0 %)
2016	606.24	8.0 %	242.13	0.8 %	98.81	(31.2 %)
Q1 2017	180.23	25.0 %	62.02	13.3 %	33.61	26.0 %
Q2 2017	176.71	28.0 %	58.16	1.0 %	32.88	19.0 %
Q3 2017	163.01	15.3 %	53.91	(4.5 %)	26.46	1.9 %
Q4 2017	188.69	3.3 %	65.08	(11.3 %)	33.93	82.6 %
2017	708.62	16.9 %	239.16	(1.2 %)	126.88	28.4 %
Q1 2018	200.67	11.3 %	66.84	7.8 %	38.29	13.9 %
Q2 2018	214.49	21.4 %	53.28	(8.4 %)	28.26	(14.0 %)
Q3 2018	250.40	53.6 %	64.92	20.4 %	31.19	17.9 %
Q4 2018	228.04	20.9 %	65.32	0.4 %	29.53	(13.0 %)
2018	893.60	26.1 %	250.36	4.7 %	127.27	0.3 %
Q1 2019	229.68	14.5 %	65.60	(1.9 %)	27.20	(29.0 %)
Q2 2019	253.83	18.3 %	71.08	33.4 %	30.95	9.5 %
Q3 2019	220.00	(12.1 %)	62.22	(4.2 %)	31.85	2.1 %
Q4 2019	270.55	18.6 %	83.72	28.2 %	39.60	34.1 %
2019	974.06	9.0 %	282.62	12.9 %	129.59	1.8 %
Q1 2020	206.69	(10.0 %)	66.48	1.3 %	33.84	24.4 %
Q2 2020	244.30	(3.8 %)	90.81	27.7 %	53.15	71.8 %
Q3 2020	207.85	(5.5 %)	77.59	24.7 %	43.13	35.4 %
Q4 2020	230.47	(14.8 %)	68.48	(18.2 %)	19.33	(51.2 %)
2020	764.06	(21.6 %)	252.83	(10.5 %)	103.91	(19.8 %)
Q1 2021	226.29	9.5 %	87.41	31.5 %	22.69	(32.9 %)
Q2 2021	223.90	(8.4 %)	79.96	(11.9 %)	33.63	(36.7 %)
Q3 2021	219.92	5.8 %	88.16	13.6 %	49.65	15.1 %

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
2011	330.66	9.7 %	147.65	8.3 %	92.15	4.9 %
2012	378.68	14.5 %	163.11	10.5 %	92.34	0.2 %
2013	434.08	14.6 %	185.16	13.5 %	112.10	21.4 %
2014	481.96	11.0 %	209.11	12.9 %	130.95	16.8 %
2015	561.33	16.5 %	240.24	14.9 %	143.57	9.6 %
2016	606.24	8.0 %	242.13	0.8 %	98.81	(31.2 %)
2017	708.62	16.9 %	239.16	(1.2 %)	126.88	28.4 %
2018	893.60	26.1 %	250.36	4.7 %	127.27	0.3 %
2019	974.06	9.0 %	282.62	12.9 %	129.59	1.8 %
2020	764.06	(21.6 %)	252.83	(10.5 %)	103.91	(19.8 %)

Profit Performance (Million)

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	EPS Before XO Items
Q1 2012	-	-	-	-	-	-
Q2 2012	-	-	-	-	-	-
Q3 2012	-	-	-	-	-	-
Q4 2012	-	-	-	-	-	-
2012	94.27	4.8 %	0.59	-	94.27	0.59
Q1 2013	29.83	-	0.19	-	29.83	0.19
Q2 2013	30.06	-	0.19	-	24.06	0.15
Q3 2013	18.32	-	0.11	-	18.32	0.11
Q4 2013	33.29	-	0.21	-	33.29	0.21
2013	111.50	18.3 %	0.70	-	111.50	0.70
Q1 2014	34.23	14.7 %	0.21	-	34.23	0.21
Q2 2014	35.60	18.4 %	0.22	-	35.60	0.22
Q3 2014	25.42	38.7 %	0.16	-	25.42	0.16
Q4 2014	33.71	1.2 %	0.21	-	33.71	0.21
2014	128.95	15.6 %	0.81	-	128.95	0.81
Q1 2015	41.01	19.8 %	0.26	9.80	31.21	0.20
Q2 2015	36.89	3.6 %	0.23	-	36.89	0.23
Q3 2015	27.69	8.9 %	0.17	-	27.69	0.17
Q4 2015	35.75	6.0 %	0.22	-	35.75	0.22
2015	141.33	9.6 %	0.88	9.80	131.53	0.82
Q1 2016	21.14	(48.5 %)	0.13	-	21.14	0.13
Q2 2016	20.63	(44.1 %)	0.13	-	20.63	0.13
Q3 2016	20.73	(25.1 %)	0.13	-	20.73	0.13
Q4 2016	10.48	(70.7 %)	0.07	-	10.48	0.07
2016	72.96	(48.4 %)	0.46	-	72.96	0.46
Q1 2017	27.97	32.3 %	0.17	-	27.97	0.17
Q2 2017	25.66	24.4 %	0.16	-	25.66	0.16
Q3 2017	23.59	13.8 %	0.15	-	23.59	0.15
Q4 2017	30.76	193.4 %	0.19	-	30.76	0.19
2017	107.97	48.0 %	0.67	-	107.97	0.67
Q1 2018	30.88	10.4 %	0.19	-	30.88	0.19
Q2 2018	19.93	(22.3 %)	0.12	-	19.93	0.12
Q3 2018	21.31	(9.7 %)	0.13	-	21.31	0.13
Q4 2018	17.70	(42.5 %)	0.11	-	17.70	0.11
2018	89.81	(16.8 %)	0.56	-	89.81	0.56
Q1 2019	24.17	(21.7 %)	0.15	-	24.17	0.15
Q2 2019	20.01	0.4 %	0.13	-	20.01	0.13
Q3 2019	21.17	(0.6 %)	0.13	-	21.17	0.13
Q4 2019	27.65	56.2 %	0.17	-	27.65	0.17
2019	93.00	3.5 %	0.58	-	93.00	0.58
Q1 2020	24.94	3.2 %	0.16	-	24.94	0.16
Q2 2020	39.10	95.4 %	0.24	(4.99)	44.10	0.28
Q3 2020	36.57	72.7 %	0.23	-	36.57	0.23
Q4 2020	30.21	9.3 %	0.19	-	30.21	0.19
2020	130.83	40.7 %	0.82	(4.99)	135.82	0.85
Q1 2021	35.54	42.5 %	0.22	-	35.54	0.22
Q2 2021	40.31	3.1 %	0.25	-	40.31	0.25
Q3 2021	3.58	(90.2 %)	0.02	(39.18)	42.76	0.27

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	EPS Before XO Items
2011	89.94	12.6 %	0.56	-	89.94	0.56
2012	94.27	4.8 %	0.59	-	94.27	0.59
2013	111.50	18.3 %	0.70	-	111.50	0.70
2014	128.95	15.6 %	0.81	-	128.95	0.81
2015	141.33	9.6 %	0.88	9.80	131.53	0.82
2016	72.96	(48.4 %)	0.46	-	72.96	0.46
2017	107.97	48.0 %	0.67	-	107.97	0.67
2018	89.81	(16.8 %)	0.56	-	89.81	0.56
2019	93.00	3.5 %	0.58	-	93.00	0.58
2020	130.83	40.7 %	0.82	(4.99)	135.82	0.85

Profitability

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2012	-	-	-
Q2 2012	-	-	-
Q3 2012	-	-	-
Q4 2012	-	-	-
2012	43.07 %	27.97 %	24.89 %
Q1 2013	-	-	-
Q2 2013	-	-	-
Q3 2013	-	-	-
Q4 2013	42.66 %	27.60 %	24.31 %
2013	42.66 %	28.96 %	25.69 %
Q1 2014	42.66 %	27.85 %	24.35 %
Q2 2014	43.18 %	29.90 %	26.17 %
Q3 2014	43.70 %	30.34 %	26.97 %
Q4 2014	43.39 %	30.09 %	26.75 %
2014	43.39 %	30.07 %	26.75 %
Q1 2015	41.90 %	29.13 %	25.73 %
Q2 2015	42.55 %	28.68 %	25.19 %
Q3 2015	42.80 %	29.71 %	24.29 %
Q4 2015	42.80 %	31.06 %	23.43 %
2015	42.80 %	31.06 %	23.43 %
Q1 2016	42.42 %	30.79 %	21.09 %
Q2 2016	41.32 %	30.64 %	18.24 %
Q3 2016	40.74 %	29.96 %	16.90 %
Q4 2016	39.94 %	25.11 %	12.04 %
2016	39.94 %	25.10 %	12.03 %
Q1 2017	38.83 %	24.74 %	12.43 %
Q2 2017	36.71 %	24.09 %	12.46 %
Q3 2017	35.22 %	23.41 %	12.48 %
Q4 2017	33.75 %	25.39 %	15.24 %
2017	33.75 %	25.39 %	15.24 %
Q1 2018	33.46 %	26.03 %	15.21 %
Q2 2018	31.18 %	25.45 %	13.71 %
Q3 2018	29.28 %	24.60 %	12.04 %
Q4 2018	28.02 %	24.14 %	10.05 %
2018	28.02 %	24.14 %	10.05 %
Q1 2019	27.00 %	22.96 %	9.01 %
Q2 2019	27.75 %	22.56 %	8.65 %
Q3 2019	28.36 %	23.59 %	8.92 %
Q4 2019	29.01 %	23.82 %	9.55 %
2019	29.01 %	23.82 %	9.55 %
Q1 2020	29.81 %	25.12 %	9.86 %
Q2 2020	32.21 %	27.70 %	12.52 %
Q3 2020	34.28 %	29.29 %	14.34 %
Q4 2020	34.11 %	28.49 %	15.27 %
2020	33.09 %	27.20 %	17.78 %
Q1 2021	35.68 %	26.87 %	16.11 %
Q2 2021	35.28 %	25.58 %	16.05 %
Q3 2021	35.98 %	26.21 %	16.52 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
2011	44.65 %	31.79 %	27.20 %
2012	43.07 %	27.97 %	24.89 %
2013	42.66 %	28.96 %	25.69 %
2014	43.39 %	30.07 %	26.75 %
2015	42.80 %	31.06 %	23.43 %
2016	39.94 %	25.10 %	12.03 %
2017	33.75 %	25.39 %	15.24 %
2018	28.02 %	24.14 %	10.05 %
2019	29.01 %	23.82 %	9.55 %
2020	33.09 %	27.20 %	17.78 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2012	-	-	-
Q2 2012	-	-	-
Q3 2012	-	-	-
Q4 2012	-	-	-
Q1 2013	45.15 %	31.89 %	28.45 %
Q2 2013	42.11 %	24.00 %	22.10 %
Q3 2013	38.24 %	23.34 %	19.03 %
Q4 2013	44.45 %	30.42 %	26.82 %
Q1 2014	44.83 %	32.21 %	28.04 %
Q2 2014	44.12 %	32.25 %	29.26 %
Q3 2014	41.11 %	26.05 %	23.36 %
Q4 2014	43.26 %	29.45 %	26.04 %
Q1 2015	39.11 %	28.49 %	24.10 %
Q2 2015	46.28 %	30.21 %	26.86 %
Q3 2015	42.37 %	30.62 %	20.24 %
Q4 2015	43.16 %	34.31 %	22.67 %
Q1 2016	37.98 %	27.65 %	14.66 %
Q2 2016	41.68 %	29.60 %	14.94 %
Q3 2016	39.95 %	27.83 %	14.67 %
Q4 2016	40.16 %	17.59 %	5.74 %
Q1 2017	34.41 %	25.82 %	15.52 %
Q2 2017	32.91 %	26.06 %	14.52 %
Q3 2017	33.07 %	24.41 %	14.47 %
Q4 2017	34.49 %	25.21 %	16.30 %
Q1 2018	33.31 %	28.10 %	15.39 %
Q2 2018	24.84 %	23.98 %	9.29 %
Q3 2018	25.93 %	21.86 %	8.51 %
Q4 2018	28.65 %	23.30 %	7.76 %
Q1 2019	28.56 %	22.87 %	10.52 %
Q2 2019	28.00 %	22.30 %	7.88 %
Q3 2019	28.28 %	26.14 %	9.62 %
Q4 2019	30.94 %	24.16 %	10.22 %
Q1 2020	32.17 %	28.77 %	12.07 %
Q2 2020	37.17 %	32.12 %	18.05 %
Q3 2020	37.33 %	33.16 %	17.59 %
Q4 2020	29.72 %	20.18 %	13.11 %
Q1 2021	38.63 %	22.24 %	15.70 %
Q2 2021	35.71 %	27.50 %	18.00 %
Q3 2021	40.09 %	35.31 %	19.45 %

Per Share Data (Riyal)

Compared With The

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
Q1 2012	-	-	-	-
Q2 2012	-	-	-	-
Q3 2012	-	-	-	-
Q4 2012	-	-	-	-
Q1 2013	160.00	-	-	3.74
Q2 2013	160.00	-	-	3.67
Q3 2013	160.00	-	-	3.78
Q4 2013	160.00	0.70	0.66	3.66
Q1 2014	160.00	0.72	0.69	3.87
Q2 2014	160.00	0.76	0.76	7.88
Q3 2014	160.00	0.80	0.80	8.04
Q4 2014	160.00	0.81	0.81	8.25
Q1 2015	160.00	0.85	0.79	8.51
Q2 2015	160.00	0.86	0.80	8.27
Q3 2015	160.00	0.87	0.81	8.44
Q4 2015	160.00	0.88	0.82	8.66
Q1 2016	160.00	0.76	0.76	8.80
Q2 2016	160.00	0.66	0.66	8.37
Q3 2016	160.00	0.61	0.61	8.50
Q4 2016	160.00	0.46	0.46	8.56
Q1 2017	160.00	0.50	0.50	8.75
Q2 2017	160.00	0.53	0.53	8.89
Q3 2017	160.00	0.55	0.55	9.04
Q4 2017	160.00	0.67	0.67	8.67
Q1 2018	160.00	0.69	0.69	8.85
Q2 2018	160.00	0.66	0.66	8.98
Q3 2018	160.00	0.64	0.64	9.11
Q4 2018	160.00	0.56	0.56	9.24
Q1 2019	160.00	0.52	0.52	9.40
Q2 2019	160.00	0.52	0.52	9.51
Q3 2019	160.00	0.52	0.52	9.63
Q4 2019	160.00	0.58	0.58	9.79
Q1 2020	160.00	0.59	0.59	9.95
Q2 2020	160.00	0.71	0.74	10.21
Q3 2020	160.00	0.80	0.83	10.42
Q4 2020	160.00	0.82	0.85	10.62
Q1 2021	160.00	0.88	0.92	10.47
Q2 2021	160.00	0.89	0.89	10.73
Q3 2021	160.00	0.69	0.93	10.75

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
2011	160.00	0.56	0.56	2.96
2012	160.00	0.59	0.59	3.55
2013	160.00	0.70	0.70	3.66
2014	160.00	0.81	0.81	8.25
2015	160.00	0.88	0.82	8.66
2016	160.00	0.46	0.46	8.56
2017	160.00	0.67	0.67	8.67
2018	160.00	0.56	0.56	9.24
2019	160.00	0.58	0.58	9.79
2020	160.00	0.82	0.85	10.62

Multiple Ratios (End of Period Price)

Compared With The

Period	P/E	Adjusted P/E	Price/book
Q1 2012	-	-	-
Q2 2012	-	-	-
Q3 2012	-	-	-
Q4 2012	-	-	-
Q1 2013	-	-	-
Q2 2013	-	-	-
Q3 2013	-	-	-
Q4 2013	-	-	-
Q1 2014	-	-	-
Q2 2014	-	-	-
Q3 2014	51.42	51.42	5.14
Q4 2014	48.92	48.92	4.78
Q1 2015	51.53	55.54	5.14
Q2 2015	54.13	58.30	5.61
Q3 2015	44.33	47.69	4.57
Q4 2015	41.63	44.73	4.24
Q1 2016	36.41	36.41	3.14
Q2 2016	45.86	45.86	3.60
Q3 2016	36.32	36.32	2.62
Q4 2016	68.31	68.31	3.64
Q1 2017	61.37	61.37	3.50
Q2 2017	58.51	58.51	3.49
Q3 2017	47.94	47.94	2.91
Q4 2017	41.25	41.25	3.21
Q1 2018	39.28	39.28	3.07
Q2 2018	37.68	37.68	2.76
Q3 2018	32.21	32.21	2.27
Q4 2018	33.55	33.55	2.04
Q1 2019	35.91	35.91	1.98
Q2 2019	30.97	30.97	1.69
Q3 2019	32.09	32.09	1.73
Q4 2019	27.16	27.16	1.61
Q1 2020	24.17	24.17	1.42
Q2 2020	23.40	22.41	1.62
Q3 2020	27.10	26.08	2.08
Q4 2020	26.52	25.54	2.04
Q1 2021	24.66	23.82	2.08
Q2 2021	33.33	33.33	2.77
Q3 2021	42.10	31.02	2.68

Period	P/E	Adjusted P/E	Price/book
2011	-	-	-
2012	-	-	-
2013	-	-	-
2014	48.92	48.92	4.78
2015	41.63	44.73	4.24
2016	68.34	68.34	3.64
2017	41.25	41.25	3.21
2018	33.55	33.55	2.04
2019	27.16	27.16	1.61
2020	26.52	25.54	2.04

Business Segments (Million)

Compared With The

Period	healthy services and other	Pharmaceutical sales revenue - Pharmacies
Q1 2017	150.74	29.49
Q2 2017	147.45	29.26
Q3 2017	136.70	26.31
Q4 2017	155.95	32.73
Q1 2018	140.85	59.82
Q2 2018	143.64	71.39
Q3 2018	140.83	109.03
Q4 2018	154.81	73.23
Q1 2019	146.91	82.77
Q2 2019	151.05	102.78
Q3 2019	149.00	71.00
Q4 2019	177.92	92.62
Q1 2020	152.48	54.21
Q2 2020	192.83	51.46
Q3 2020	47.34	35.26
Q4 2020	185.43	45.04
Q1 2021	168.82	57.47
Q2 2021	163.87	60.02
Q3 2021	180.27	39.64

Period	healthy services and other	Pharmaceutical sales revenue - Pharmacies
2011	244.33	86.33
2012	274.90	103.78
2013	317.00	117.11
2014	360.30	121.61
2015	451.60	109.71
2016	552.40	89.11
2017	590.84	117.78
2018	580.13	313.47
2019	624.88	349.18
2020	578.09	185.97

Analysts Estimates (Million)

Item	Q3 2021 (e)	Q3 2021 (a)	Change‬
Average	40.90	3.58	(91.2 %)

Estimates vs Actual (Million)

Item	Q3 2021 (e)	Q3 2021 (a)	Change
Al Rajhi Capital	37.00	3.58	(90.3) %
SNB Capital	40.00	3.58	(91.0) %
AlJazira Capital	41.40	3.58	(91.4) %
OSOOL AND BAKHEET	42.10	3.58	(91.5) %
Beltone Financial	44.00	3.58	(91.9) %

Financial Ratios

	Current
Market Cap (M Riyal)	6,144.00
Enterprise Value (EV) (M)	5,905.92
Shares Outstanding ((M))	160.00
EPS ( Riyal) (TTM)	2.04
Book Value (BV) ( Riyal)	12.11
Par Value ( Riyal)	10.00
Adjusted P/E (Last12)	23.23
P/E (TTM)	18.83
Price/book	3.17
Return on Average Assets (%) (TTM)	12.5
Return on Average Equity (%) (TTM)	17.3

Al Hammadi Holding (ALHAMMADI)

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Al Hammadi’s net profit falls 21% to SAR 79.4 mln in 9M 2021

View other reports

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profit Performance (Million)

Profit Performance (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million)

Revenue by Business Segment (Latest) 2021 Q3

Analysts Estimates (Million)

Analysts Estimates (Million)

Estimates vs Actual (Million)

Estimates Accuracy

Financial Ratios

Share Price

Al Hammadi Holding (ALHAMMADI)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

×

Al Hammadi’s net profit falls 21% to SAR 79.4 mln in 9M 2021

View other reports

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profit Performance (Million)

Profit Performance (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million) Q3 2021

Revenue by Business Segment (Latest) 2021 Q3

Analysts Estimates (Million)

Analysts Estimates (Million)

Estimates vs Actual (Million)

Estimates Accuracy

Financial Ratios

Share Price

Al Hammadi Holding (ALHAMMADI)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Business Segments (Million)